Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 23,294 shares at $58.01 ($1.4M) on 2025-02-25, disclosed to the SEC on 2025-02-27.
Scheduled sale ($1.4M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.01 | 9,300 | $539K | 39.9% |
| 2 | $58.67 | 700 | $41K | 3.0% |
| 3 | $58.09 | 9,400 | $546K | 40.3% |
| 4 | $58.65 | 600 | $35K | 2.6% |
| 5 | $58.25 | 1,597 | $93K | 6.9% |
| 6 | $58.25 | 1,597 |
| $93K |
| 6.9% |
| 7 | $58.74 | 100 | $6K | 0.4% |
| Total | $58.11 avg | 23,294 | $1.4M | 100% |
| Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |
| HALO | SELL | 2024-06-20 | $494K | — | Filing → |